Juan Camilo Arjona Ferreira was appointed CMO at Organon & Co. in July 2025.
2 reports, 1 independent
Updated Jul 10
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Juan Camilo Arjona Ferreira was appointed CMO at Organon & Co. in July 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Juan Camilo Arjona Ferreira
researcher
Nothing else this week.
-
Organon & Co.
pharmaceutical company
Nothing else this week.
Coverage
Newest first; wire copies grouped- Insider MonkeyOrganon & Co. (OGN) Announces Discontinuation of the OG-6219 Clinical Development Program Organon & Co. (NYSE:OGN) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On July 2, Orga
- Unknown outlet